References
- Jaffe, E.S., Harris, N.L., Stein, H. and Vardiman, J.W. (2001) World Health Organization classification of tumours. In Pathology and Genetics of Tumours of Haemopoietic and Lymphoid Tissues. Lyon: IARC Press.
- Wolowiec, D., Berger, F., Ffrench, P., Bryon, P.A. and French, M. (1999) "CDK1 and Cyclin A expression is linked to cell prolifera-tion and associated with prognosis in non-Hodgkin's lymphomas", Leukemia and Lymphoma, 35, 147 — 157.
- Shipp, MA. (1993) "A predictive model for aggressive non-Hodgkin's lymphoma", New England Journal of Medicine, 329, 987 —994.
- Willis, T.G. and Dyer, M.J.S. (2000) "The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies", Blood, 96, 808–822.
- Kearney, L. (1999) "The impact of the new FISH technologies on the cytogenetics of haematological malignancies", British Journal of Haematology, 104, 648 —658.
- Jalal, S.M., Law, ME., Stamberg, J., Fonseca, R., Seely, J.R., Myers, W.H., et al. (2001) "Detection of diagnostically critical, often hidden, anomalies in complex karyotypes of haematological disorders using multicolour fluorescence in situ hybridisation", British Journal of Haematology, 112, 975–980.
- Gaiter, K.C. and Warnke, R.A. (2001) Diffuse large B-cell lymphoma. In World Health Organization Classification of Tumours. Pathology, and Genetics of Tumours of Haemopoietic and Lymphoid Tissues. Jaffe, ES., Harris, N.L., Stein, H., Vardiman, J.W. (ed.) pp 171–174. Lyon: IARC Press.
- Strauchen, J.A. (2003) "Primary bone marrow B-cell lymphoma: Report of four cases", The Mount Sinai Journal of Medicine, 70, 133— 138.
- Conlan, M.G., Bast, M., Armitage, J.O. and Weisenburger, D.D. (1990) "Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group", Journal of Clinical Oncology, 8, 1163–1172.
- Nanjangud, G., Rao, PH., Hedge, A., Teruya-Feldstein, J., Donnelly, G., Qin, J., et al. (2002) "Spectral karyotyping identifies new rearrangements, translocations, and clinical associations in diffuse large B-cell lymphoma", Blood, 99, 2554–2561.
- Dorkeld, F., Bernheim, A., Dessen, P. and Huret, J.L. (1999) "A database on cytogenetics in haematology and oncology", Nucleic Acids Research, 27, 353–354.
- Gascoyne, RD. (1997) "Pathologic prognostic factors in diffuse aggressive non-Hodgkin's lymphoma", Lymphoma, 11, 847–862.
- Korsemeyer, S.J. (1999) "BCL-2 gene family and the regulation of programmed cell death", Cancer Research (Suppl.), 59, 1693s — 1700s.
- Coiffier, B., Haioun, C., Ketterer, N., Engert, A., Tilly, H., Ma, D., et al. (1998) "Rituximab (Anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study", Blood, 92, 1927 — 1932.
- Coiffier, B., Lepage, E., Briere, J., Herbrecht, R., Tilly, H., Bouabdallah, R., et al. (2002) "CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with DLBL", New England Journal of Medicine, 346, 235–242.
- Harris, N.L., Stein, H., Coupland, SE., Hummel, M., Favera, Pasqualucci, L., et al. (2001) "New approaches to lymphoma diagnosis", ASH (Educational Program) 194–220.